Under the current circumstance, unless there can be a demonstration of a reduction in the prion activity, you're correct. The legislation is drafted in such a way that it provides the opportunity for further research to be done following these processes, to determine if in fact it does achieve a prion inactivation or deactivation process. So again, the legislation was written on a far-sighted basis to say, if we can look at these technologies and do the assessments to demonstrate whether they do achieve in fact a prion degradation, then it does open up the door for, again, looking at alternate uses of those products. So it is embedded in the legislation, to give us that capacity. But again, it will take time for the industry to work with us to develop the assessment tools on those technologies, to ensure that we're not creating a further environmental issue.
On February 28th, 2007. See this statement in context.